Popular on Rezul
- Kasinohai Audit: Most Slots Could Be Affected by Finland's Draft Gambling Rules
- eCopier Solutions Surpasses 3,000 Five-Star Google Reviews and Maintains Perfect Five-Star Rating
- Titan Pressure Washing Shows The Power Of Complete Exterior Cleaning On A Roof And Concrete Project
- Allstream Energy Partners Expands AI-Optimized Website Development Division to Meet Growing Demand in GEO / AEO Services
- Two Attorneys at The Stanley Law Group Named to 2026 South Carolina Super Lawyers List
- Talentica Software Earns a Place Among India's Top 100 Great Mid-size Workplaces 2026
- Prepare for Hurricane Season While Increasing Their Home's Market Appeal
- Host Reports $11,000 Property Loss Following Guest Stay
- Senco Home Services Expands Residential Construction Services
- J&J Exterminating Mourns the Passing of Founder Bobby John Sr
Similar on Rezul
- Aderra Opens in Magnolia, Texas, Offering a New Model for 62+ Homeownership
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
- U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
- Missouri Hemp Businesses File Federal Lawsuit Challenging HB 2641
- CCHR: Congressional Hearing Revives Lessons from MKULTRA Era – Why Past Psychiatric Human Rights Abuses Demand Vigilance Today
- Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
- Lineus Medical Renews Agreement with Vizient, Delivering Enhanced Value for Vizient Members
- Qscription Technologies Appoints Radiology Industry Veteran Elliot Silverman to Advisory Board
- Mr. Hospital Bed Helps Home Care Buyers Find the Right Hospital Bed
- World Cup Crowds Are a Stress Test for America's Restrooms
Dosi Announces the World's Most Capable Peptide, GLP-1 and TRT Tracking App
Rezul News/10741321
Available internationally through the Apple App Store and Google Play, Dosi brings 180+ compound profiles, personal tracking, injection-site history, a reconstitution calculator, and the Ask Dosi intelligence layer in one mobile platform.
ST. AUGUSTINE, Fla. - Rezul -- Dosi, a Health & Fitness app from 3WB Holdings, announced mobile availability on iOS and Android. Built as the world's most capable peptide tracker and personal protocol organizer, Dosi gives people managing complex routines one place for their schedules, logs, reference material, and routine history.
Dosi is available internationally through the Apple App Store and Google Play. Its current public product listings describe features including personal dose logging, schedules and reminders, a body-map record for injection-site rotation, a reconstitution calculator, protocol history, and a 180+ compound reference library.
The platform is designed around personal tracking and educational reference across routine categories represented in Dosi's current public materials, including GLP-1, TRT, HRT, fertility and IVF medication, peptides, growth-hormone routines, nootropics, and longevity-related compounds. For people organizing GLP-1 routines, the app can serve as a semaglutide tracker or tirzepatide tracker. Category coverage is not a medical recommendation, suitability determination, or treatment guidance.
More on Rezul News
Dosi also includes Ask Dosi, an in-app AI intelligence layer described in its current store listings as a research-informed information feature. Ask Dosi is intended to help users find relevant educational and tracking information inside the product; it is not a clinician, does not diagnose or prescribe, and is not a substitute for qualified healthcare guidance.
"People managing complex routines often end up moving between calendars, notes, screenshots, and spreadsheets," said Dean White, Founder and CEO of Dosi. "We built Dosi to give them one place to organize the information they personally track and bring better context to conversations with their qualified healthcare providers."
Dosi's free tier allows users to start organizing a protocol. Premium plans add expanded product features. The app is intended for informational and organizational use only; it does not provide medical advice, diagnosis, or treatment. Users should consult a qualified healthcare provider regarding medical decisions, prescriptions, dosing, or treatment.
More on Rezul News
About Dosi: Dosi is a personal protocol-tracking app for iOS and Android, built by 3WB Holdings in St. Augustine, Florida.
Media Contact: Dosi / 3WB Holdings — press@heydosi.com
Website: https://heydosi.com
Press kit: Dosi Press (https://heydosi.com/en/press?utm_source=prlog&utm_medium=press_release&utm_campaign=dosi_cross_platform_availability_2026_07)
Dosi is available internationally through the Apple App Store and Google Play. Its current public product listings describe features including personal dose logging, schedules and reminders, a body-map record for injection-site rotation, a reconstitution calculator, protocol history, and a 180+ compound reference library.
The platform is designed around personal tracking and educational reference across routine categories represented in Dosi's current public materials, including GLP-1, TRT, HRT, fertility and IVF medication, peptides, growth-hormone routines, nootropics, and longevity-related compounds. For people organizing GLP-1 routines, the app can serve as a semaglutide tracker or tirzepatide tracker. Category coverage is not a medical recommendation, suitability determination, or treatment guidance.
More on Rezul News
- What's New in Hokkaido, Autumn 2026
- Charlotte Investors Name Priority Property Group Among the City's Best Property Management Companies
- Winvest Management Delivers Professional Property Management Services for Miami Owners
- Global Real Estate Pro Debuts First‑of‑Its‑Kind Three‑Stream Platform
- Hand Dryer USA Says Green Buildings Have a Blind Spot
Dosi also includes Ask Dosi, an in-app AI intelligence layer described in its current store listings as a research-informed information feature. Ask Dosi is intended to help users find relevant educational and tracking information inside the product; it is not a clinician, does not diagnose or prescribe, and is not a substitute for qualified healthcare guidance.
"People managing complex routines often end up moving between calendars, notes, screenshots, and spreadsheets," said Dean White, Founder and CEO of Dosi. "We built Dosi to give them one place to organize the information they personally track and bring better context to conversations with their qualified healthcare providers."
Dosi's free tier allows users to start organizing a protocol. Premium plans add expanded product features. The app is intended for informational and organizational use only; it does not provide medical advice, diagnosis, or treatment. Users should consult a qualified healthcare provider regarding medical decisions, prescriptions, dosing, or treatment.
More on Rezul News
- CRG Awarded NASA SEWP VI Contracts in Categories B and C
- Heidi G. Villari of The Villari Firm, PLLC Named to Super Lawyers for the Tenth Consecutive Year
- Noida Luxury Launches Dedicated Advisory Desk for Purvanchal Skyline Vista in Sector 94, Noida
- Elevate Your Sneakers With Crep Protect Trek Laces
- Meet Privateer: Tucson's High-Tech Security Force Built With Paramilitary Precision
About Dosi: Dosi is a personal protocol-tracking app for iOS and Android, built by 3WB Holdings in St. Augustine, Florida.
Media Contact: Dosi / 3WB Holdings — press@heydosi.com
Website: https://heydosi.com
Press kit: Dosi Press (https://heydosi.com/en/press?utm_source=prlog&utm_medium=press_release&utm_campaign=dosi_cross_platform_availability_2026_07)
Source: Dosi / 3WB Holdings
0 Comments
Latest on Rezul News
- New Research Puts the Cost of Enterprise Decision Delay at $630 Billion a Year Across the Global 2000
- David Weekley Homes Debuts Lifestyle-Enhancing Amenity Package at Georgia's Old Mill Preserve
- Cover Story about Matthew Cossolotto – Author of Harness Your PromisePower -- Published in July 2026 Enterprise World Magazine
- Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
- New Research: Deterministic Decompilation of Hermes Bytecode Back to Readable JavaScript
- Treasure Coast, Florida 2026 Fall Real Estate Forecast
- Port Houston | Market Report Q2 2026
- Lionheart Holdings and KEO Energy Sign Letter of Intent for Proposed Business Combination
- Marcus Christ Announces Singles: "The Hammer Goes Click" and "You Hate Me, I Hate You"
- Fatal FOMO May be Your Last Roll of the Dice
- Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board
- Allstream Energy Partners Returns as a Media Partner for the 2026 API Inspection & Mechanical Integrity Summit in San Antonio
- Neighborhood Housing Services of NYC to Host Housing Resource Fair Saturday, July 25, in the Bronx
- IREIS Properties: London Property Market Enters New Growth Phase, Presenting Strategic for Overseas
- O'Dwyer Homes at Lake Society: Simple Living. Exceptional Value
- Tour, Save, and Win at O'Dwyer Homes Communities Across Metro Atlanta
- PokerStars & Ladbrokes veteran buys into Finnish news media Rahapelisanomat
- Former Judge Chris Oldner Honored as Best Lawyer by "D Magazine" for 6th Straight Year
- Premier Workspaces Renews and Expands Its Sherman Oaks Location at Valley Executive Tower
- Missouri Hemp Businesses File Federal Lawsuit Challenging HB 2641